Funding secured for accelerated market development
We are very happy to announce that we have completed a CHF 6.0m first closing of our Series B financing round. This enables us to accelerate market development and growth with rqmicro.COUNT, our latest rapid pathogen detection platform for safe water.
“We are at the start of a revolution in water microbiology. rqmicro.COUNT enables customers to routinely analyze specific bacteria on a single-cell level and to generate actionable data to maintain and improve water safety. This is a breakthrough that will generate tremendous value in our sector and for the safety of consumers” said Dr. Hans-Anton Keserue, CEO of rqmicro.
“In order to further accelerate the international market development, we are planning to conclude the Series B growth round with a second closing of CHF 8.0m in the first half of 2021” said Tobias Schaad, CFO/COO of rqmicro.